PMC6384415_01
At admission (A), the patient presented with ptosis of the right eye, and repetitive stimulation of the right facial nerve revealed neuromuscular dysfunction with a decrement of 14%. Two weeks after discontinuation of immunotherapy and treatment with pyridostigmine and prednisone, the patient showed no clinical signs of myasthenia and no pathological decrement could be detected (B).
fonc-09-00084-g0001.jpg
PMC6384415_01_fonc-09-00084-g0001.jpg
F1
Repetitive stimulation of the right facial nerve revealed an action potential decrement of 14% (Figure 1A). Repetitive nerve stimulation was repeated, and pathological decrement could not be observed any longer (Figure 1B).